chr16-1206259-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_021098.3(CACNA1H):​c.2759C>T​(p.Thr920Met) variant causes a missense change. The variant allele was found at a frequency of 0.00259 in 1,574,574 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T920R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0016 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0027 ( 9 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

3
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 3.89

Publications

6 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010669082).
BP6
Variant 16-1206259-C-T is Benign according to our data. Variant chr16-1206259-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 376802.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0016 (244/152340) while in subpopulation NFE AF = 0.00241 (164/68024). AF 95% confidence interval is 0.00211. There are 2 homozygotes in GnomAd4. There are 101 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 244 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.2759C>T p.Thr920Met missense_variant Exon 12 of 35 ENST00000348261.11 NP_066921.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.2759C>T p.Thr920Met missense_variant Exon 12 of 35 1 NM_021098.3 ENSP00000334198.7
CACNA1HENST00000569107.6 linkc.2759C>T p.Thr920Met missense_variant Exon 12 of 34 1 ENSP00000454990.2
CACNA1HENST00000711493.1 linkc.2759C>T p.Thr920Met missense_variant Exon 12 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.2759C>T p.Thr920Met missense_variant Exon 12 of 34 1 ENSP00000455840.1
CACNA1HENST00000711450.1 linkc.2759C>T p.Thr920Met missense_variant Exon 12 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.2759C>T p.Thr920Met missense_variant Exon 12 of 35 1 ENSP00000457555.2
CACNA1HENST00000638323.1 linkc.2720C>T p.Thr907Met missense_variant Exon 12 of 35 5 ENSP00000492267.1
CACNA1HENST00000562079.6 linkc.2759C>T p.Thr920Met missense_variant Exon 12 of 34 1 ENSP00000454581.2
CACNA1HENST00000711438.1 linkc.2720C>T p.Thr907Met missense_variant Exon 12 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.2759C>T p.Thr920Met missense_variant Exon 12 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.2759C>T p.Thr920Met missense_variant Exon 12 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.2759C>T p.Thr920Met missense_variant Exon 12 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.2759C>T p.Thr920Met missense_variant Exon 12 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.2759C>T p.Thr920Met missense_variant Exon 12 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.2759C>T non_coding_transcript_exon_variant Exon 12 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.2759C>T non_coding_transcript_exon_variant Exon 12 of 34 5 ENSP00000492650.2
CACNA1HENST00000639478.1 linkn.2759C>T non_coding_transcript_exon_variant Exon 12 of 35 5 ENSP00000491945.1
CACNA1HENST00000640028.1 linkn.*672C>T non_coding_transcript_exon_variant Exon 12 of 35 5 ENSP00000491488.1
CACNA1HENST00000711442.1 linkn.*2206C>T non_coding_transcript_exon_variant Exon 11 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.2759C>T non_coding_transcript_exon_variant Exon 12 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.2759C>T non_coding_transcript_exon_variant Exon 12 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.2759C>T non_coding_transcript_exon_variant Exon 12 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.2759C>T non_coding_transcript_exon_variant Exon 12 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.2759C>T non_coding_transcript_exon_variant Exon 12 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.2759C>T non_coding_transcript_exon_variant Exon 12 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.2759C>T non_coding_transcript_exon_variant Exon 12 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.2759C>T non_coding_transcript_exon_variant Exon 12 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.2759C>T non_coding_transcript_exon_variant Exon 12 of 35 ENSP00000518777.1
CACNA1HENST00000640028.1 linkn.*672C>T 3_prime_UTR_variant Exon 12 of 35 5 ENSP00000491488.1
CACNA1HENST00000711442.1 linkn.*2206C>T 3_prime_UTR_variant Exon 11 of 34 ENSP00000518758.1

Frequencies

GnomAD3 genomes
AF:
0.00160
AC:
244
AN:
152222
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000868
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000654
Gnomad ASJ
AF:
0.00576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.000376
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00241
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00225
AC:
429
AN:
190264
AF XY:
0.00222
show subpopulations
Gnomad AFR exome
AF:
0.00126
Gnomad AMR exome
AF:
0.00113
Gnomad ASJ exome
AF:
0.00380
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000445
Gnomad NFE exome
AF:
0.00345
Gnomad OTH exome
AF:
0.00316
GnomAD4 exome
AF:
0.00269
AC:
3832
AN:
1422234
Hom.:
9
Cov.:
31
AF XY:
0.00261
AC XY:
1840
AN XY:
703772
show subpopulations
African (AFR)
AF:
0.000740
AC:
24
AN:
32432
American (AMR)
AF:
0.00109
AC:
43
AN:
39608
Ashkenazi Jewish (ASJ)
AF:
0.00358
AC:
91
AN:
25440
East Asian (EAS)
AF:
0.000106
AC:
4
AN:
37608
South Asian (SAS)
AF:
0.00168
AC:
136
AN:
80718
European-Finnish (FIN)
AF:
0.000480
AC:
24
AN:
50000
Middle Eastern (MID)
AF:
0.00113
AC:
5
AN:
4406
European-Non Finnish (NFE)
AF:
0.00308
AC:
3365
AN:
1093142
Other (OTH)
AF:
0.00238
AC:
140
AN:
58880
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
231
463
694
926
1157
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
128
256
384
512
640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00160
AC:
244
AN:
152340
Hom.:
2
Cov.:
33
AF XY:
0.00136
AC XY:
101
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.000866
AC:
36
AN:
41578
American (AMR)
AF:
0.000653
AC:
10
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00576
AC:
20
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4830
European-Finnish (FIN)
AF:
0.000376
AC:
4
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00241
AC:
164
AN:
68024
Other (OTH)
AF:
0.00189
AC:
4
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
14
28
42
56
70
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.177
Hom.:
6952
Bravo
AF:
0.00168
TwinsUK
AF:
0.00189
AC:
7
ALSPAC
AF:
0.00285
AC:
11
ESP6500AA
AF:
0.000947
AC:
4
ESP6500EA
AF:
0.00465
AC:
39
ExAC
AF:
0.00228
AC:
266
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CACNA1H: BS1, BS2 -

Dec 02, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 01, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

See cases Benign:1
Jan 03, 2020
Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ACMG classification criteria: BS1, BP1, BP4 -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.028
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.15
CADD
Benign
14
DANN
Benign
0.91
DEOGEN2
Benign
0.36
T;.;.;.
Eigen
Benign
-0.87
Eigen_PC
Benign
-0.62
FATHMM_MKL
Benign
0.39
N
LIST_S2
Uncertain
0.86
D;D;D;.
M_CAP
Uncertain
0.24
D
MetaRNN
Benign
0.011
T;T;T;T
MetaSVM
Uncertain
-0.067
T
MutationAssessor
Benign
-1.8
N;.;N;N
PhyloP100
3.9
PrimateAI
Benign
0.45
T
PROVEAN
Benign
5.0
N;.;N;N
REVEL
Benign
0.28
Sift
Benign
1.0
T;.;T;T
Sift4G
Benign
1.0
T;.;T;T
Polyphen
0.0060
B;.;B;B
Vest4
0.29
MVP
0.43
ClinPred
0.0041
T
GERP RS
2.9
Varity_R
0.038
gMVP
0.66
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs59052554; hg19: chr16-1256259; COSMIC: COSV100673714; COSMIC: COSV100673714; API